Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
When you inject early, you increase the concentration of drug molecules competing for those receptors
However, it was not possible to establish whether these histological effects were solely determined by reductions in body weight
Product Attributes CAS # : 75921-69-6 Molecular Formula : C78H111N21O19 Sequence (AA) : Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Molecular Weight : 1646.85 g/mol PubChem CID : 16132139 Half-Life : ~30-60 minutes (extended pigmentation effect lasts weeks) Synonyms : Afamelanotide, MT-I, MT-1, NDP-MSH, Scenesse, [Nle4, D-Phe7]-alpha-MSH Type : Synthetic research peptide (alpha-MSH analog, MC1R agonist) Research Focus : Skin Pigmentation & Photoprotection, Melanocortin Signaling Scientific References Afamelanotide for prevention of phototoxicity in patients with erythropoietic protoporphyria Human RCT | Regulatory Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo Human RCT Photoprotection by melanocortin 1 receptor agonists Animal | In vitro Afamelanotide: a melanocortin analogue for photoprotection Observational | Animal The melanocortin-1 receptor: red hair and beyond In vitro | Observational Melanocortin 1 receptor signaling and skin pigmentation In vitro | Animal Scenesse (afamelanotide) European Medicines Agency assessment report Regulatory | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
Exercise also helps prevent weight rebound after stopping medication
Enzim ini bertanggung jawab dalam pembentukan melanin
GLP-1 anti-obesity drugs lead to substantial weight loss in the real world March 25, 2024 We know that the GLP-1 anti-obesity drugs lead to substantial weight loss in clinical trials
